CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 80 filers reported holding CATALYST BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $2,564,000 | -5.1% | 623,892 | 0.0% | 0.82% | +21.8% |
Q2 2021 | $2,701,000 | -14.1% | 623,892 | 0.0% | 0.67% | +5.2% |
Q1 2021 | $3,144,000 | +164.0% | 623,892 | +230.6% | 0.64% | +161.5% |
Q4 2020 | $1,191,000 | +39.5% | 188,714 | -5.0% | 0.24% | +44.4% |
Q3 2020 | $854,000 | -26.8% | 198,714 | 0.0% | 0.17% | -50.3% |
Q2 2020 | $1,166,000 | +22.0% | 198,714 | -9.1% | 0.34% | +6.2% |
Q1 2020 | $956,000 | -31.4% | 218,714 | +6.9% | 0.32% | -3.6% |
Q4 2019 | $1,394,000 | +23.6% | 204,677 | -10.9% | 0.33% | -8.5% |
Q3 2019 | $1,128,000 | -70.3% | 229,677 | -55.4% | 0.36% | -60.3% |
Q2 2019 | $3,792,000 | +2.9% | 514,544 | +13.3% | 0.91% | -8.1% |
Q1 2019 | $3,684,000 | +60.1% | 454,308 | +55.8% | 1.00% | +18.7% |
Q4 2018 | $2,301,000 | -61.3% | 291,625 | -47.1% | 0.84% | -58.9% |
Q3 2018 | $5,940,000 | +8.0% | 550,977 | +16.9% | 2.04% | -33.0% |
Q2 2018 | $5,502,000 | -81.5% | 471,448 | -59.0% | 3.04% | -82.9% |
Q1 2018 | $29,670,000 | +975.4% | 1,149,989 | +468.5% | 17.83% | +1045.8% |
Q4 2017 | $2,759,000 | +29.3% | 202,281 | -52.0% | 1.56% | +40.6% |
Q3 2017 | $2,133,000 | +29.9% | 421,635 | +19.4% | 1.11% | +41.9% |
Q2 2017 | $1,642,000 | – | 353,172 | – | 0.78% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |